Aardvark released exploratory data from its stopped Phase 3 HERO trial in Prader-Willi syndrome after FDA lifted the hold, and plans a redesigned Phase 3.
|Articles|February 1, 2018
Trial By Fire Solutions Expands Its SimpleTrials Clinical Trial Management System
Advertisement
Oakland, Calif., Feb. 01, 2018 (Business Wire)-Trial By Fire Solutions, a leader in web-based clinical trial management solutions that improve planning, execution and tracking of clinical studies, has expanded its SimpleTrials product, the first on-demand, subscription-based clinical trial management system (CTMS).
Developed by clinical trial professionals with over 20 years of experience, SimpleTrials supports sponsors, sites and vendors. The CTMS allows users to manage calendars, milestones, documents, subjects and payments in a scalable feature set.
The new electronic visit report (eVR) feature adds an easy-to-use report authoring and approval workflow tool for clinical monitoring teams. A template builder is available at the portfolio level for multi-study use. These features save time and provide study teams insight into site activities.
Additional features include eVR attachments; integrated action items and subject deviations; alerts; and performance metrics and reports.
These improve site activity management by eliminating the need for document exchange via email. Users access real-time information and draft and approve content more efficiently. In addition, the eVR is fully integrated with SimpleTrials’ visit calendars and eTMF to provide a comprehensive, flexible solution.
“SimpleTrials is well designed and easy to use,” said Natalie Shrock, ARNP, CCRC, vice president/site director, Shrock Clinical Research. “We hit the ground running and received excellent support from the team. Their approach is exactly what we were looking for.”
Recently, site contract and payment features were added to SimpleTrials to handle common site invoicing workflows.
“SimpleTrials clients benefit from our years of CTMS experience with well-designed eVRs, site payments and other features that are available on a secure platform at an affordable subscription price,” said Nancy Cecchettini, Trial By Fire Solutions co-founder and chief product officer.
Premium, on-demand plans provide same-day access and include the eVR and site contracts and payments features.
To learn more, stop by Booth 714 at SCOPE, Feb. 13–14 in Orlando, Fla., for a SimpleTrials demo or visit simpletrials.com.
About Trial By Fire Solutions
Trial By Fire Solutions is a global leader in web-based clinical trial management solutions focused on innovative applications to improve planning, execution and tracking of clinical studies. With its SimpleCTMS and SimpleTrials products, along with an experienced clinical technology team, Trial By Fire Solutions provides affordable eClinical solutions to teams of all sizes. For more information, visit www.simpletrials.com.
Advertisement
Related to this article
Clinical trials capture data faster than ever, but the real bottleneck is the distance between data capture and a decision teams can trust.
In today’s ACT Brief, we examine why the future of AI in trials is a trusted orchestration system rather than a single model, how coordinators rate eSource-enabled workflows, and what a bipartisan bill proposes for reusable trial networks.
The Faster Clinical Trials Act would create an FDA Center for Clinical Trial Innovation and aims to cut trial costs and enrollment time by at least 30%.
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
In today’s ACT Brief, we examine how sites can avoid both fear-driven and overly aggressive AI adoption, why community-based research needs sustained financial investment, and why patient access matters more than organizational size.
Pacing obesity trial enrollment, anchoring eligibility to stable real-world therapies, and building site and physician relationships improve retention and data quality more than aggressive recruitment or restrictive exclusion criteria do.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
2
ACT Brief: Orchestrated AI Clinical Environments, eSource Coordinator Satisfaction, and Faster Clinical Trials Act
3
Bipartisan Bill Would Build Reusable Clinical Trial Networks, With a Focus on Rare Disease
4
Clinical Trials Do Not Have a Data Problem, They Have a Decision-Readiness Problem
5